Sleep and Alzheimer's disease: A pivotal role for the suprachiasmatic nucleus

Sleep Medicine Reviews

Volumn 40, Issue , 2018, Pages 17-27

  Van Erum, Jan ^a   Van Dam, Debby ^a,b   De Deyn, Peter Paul ^a,b,c  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Hospital Network Antwerp (ZNA) Hoge Beuken and Middelheim   (Belgium)

Author keywords

Aging; Alzheimer's disease; Circadian rhythm; Dementia; Molecular clock; Sleep; Suprachiasmatic nucleus

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; GROWTH FACTOR; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; NEUROTENSIN; PROKINETICIN 2; TRANSCRIPTION FACTOR ARNTL; TRANSCRIPTION FACTOR CLOCK; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; CAENORHABDITIS ELEGANS; CIRCADIAN RHYTHM; DETERIORATION; DISEASE COURSE; DROSOPHILA MELANOGASTER; FEEDBACK SYSTEM; HUMAN; NONHUMAN; NONREM SLEEP; PARACRINE SIGNALING; PATHOPHYSIOLOGY; POPULATION RESEARCH; PROTEIN EXPRESSION; REM SLEEP; REVIEW; SLEEP TIME; SLEEP WAKING CYCLE; SUPRACHIASMATIC NUCLEUS; PHYSIOLOGY; SLEEP DISORDER;

ALZHEIMER DISEASE; CIRCADIAN RHYTHM; HUMANS; SLEEP WAKE DISORDERS; SUPRACHIASMATIC NUCLEUS;

EID: 85033467615     PISSN: 10870792     EISSN: 15322955     Source Type: Journal    
DOI: 10.1016/j.smrv.2017.07.005     Document Type: Review

References (159)

1. Prince, M., Wimo, A.G.M., Ali, G.C., Wu, Y.T., Prina, M., World Alzheimer report 2015. The global impact of dementia. An analysis of prevalence, incidence, cost and trends., 2015, Alzheimer's Disease International, London.
2. Qiu, C., Kivipelto, M., von Strauss, E., Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialog Clin Neurosci 11:2 (2009), 111–128.
3. Selkoe, D.J., Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol 6:11 (2004), 1054–1061.
4. Brion, J.P., Neurofibrillary tangles and Alzheimer's disease. Eur Neurol 40:3 (1998), 130–140.
5. Hardy, J., Allsop, D., Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 12:10 (1991), 383–388.
6. Ghiso, J., Tomidokoro, Y., Revesz, T., Frangione, B., Rostagno, A., Cerebral amyloid angiopathy and Alzheimer's disease. Hirosaki igaku Hirosaki Med J 61:Suppl. (2010), S111–S124.
7. Van Dam, D., De Deyn, P.P., Animal models in the drug discovery pipeline for Alzheimer's disease. Br J Pharmacol 164:4 (2011), 1285–1300.
8. Lyketsos, C.G., Lopez, O., Jones, B., Fitzpatrick, A.L., Breitner, J., DeKosky, S., Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 288:12 (2002), 1475–1483.
9. Van der Mussele, S., Le Bastard, N., Vermeiren, Y., Saerens, J., Somers, N., Marien, P., et al. Behavioral symptoms in mild cognitive impairment as compared with Alzheimer's disease and healthy older adults. Int J Geriatr Psychiatry 28:3 (2013), 265–275.
10. Vermeiren, Y., Van Dam, D., Aerts, T., Engelborghs, S., De Deyn, P.P., Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer's disease. J Alzheimer's Dis JAD 41:3 (2014), 819–833.
11. Van Dam, D., Vermeiren, Y., Dekker, A.D., Naude, P.J., De Deyn, P.P., Neuropsychiatric disturbances in Alzheimer's disease: what have we learned from neuropathological studies?. Curr Alzheim Res 13:10 (2016), 1145–1164.
12. Finkel, S.I., Costa e Silva, J., Cohen, G., Miller, S., Sartorius, N., Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr 8:Suppl. S3 (1997), 497–500.
13. Reisberg, B., Borenstein, J., Salob, S.P., Ferris, S.H., Franssen, E., Georgotas, A., Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 48:Suppl. (1987), 9–15.
14. Moran, M., Lynch, C.A., Walsh, C., Coen, R., Coakley, D., Lawlor, B.A., Sleep disturbance in mild to moderate Alzheimer's disease. Sleep Med 6:4 (2005), 347–352.
15. Beaulieu-Bonneau, S., Hudon, C., Sleep disturbances in older adults with mild cognitive impairment. Int Psychogeriatr IPA 21:4 (2009), 654–666.
16. Hatfield, C.F., Herbert, J., van Someren, E.J., Hodges, J.R., Hastings, M.H., Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia. Brain J Neurol 127:Pt. 5 (2004), 1061–1074.
17. Prinz, P.N., Peskind, E.R., Vitaliano, P.P., Raskind, M.A., Eisdorfer, C., Zemcuznikov, H.N., et al. Changes in the sleep and waking EEGs of nondemented and demented elderly subjects. J Am Geriatr Soc 30:2 (1982), 86–92.
18. Bliwise, D.L., Hughes, M., McMahon, P.M., Kutner, N., Observed sleep/wakefulness and severity of dementia in an Alzheimer's disease special care unit. J Gerontol Ser A Biol Sci Med Sci 50:6 (1995), M303–M306.
19. Witting, W., Kwa, I.H., Eikelenboom, P., Mirmiran, M., Swaab, D.F., Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease. Biol Psychiatry 27:6 (1990), 563–572.
20. Huang, Y.L., Liu, R.Y., Wang, Q.S., Van Someren, E.J., Xu, H., Zhou, J.N., Age-associated difference in circadian sleep-wake and rest-activity rhythms. Physiol Behav 76:4–5 (2002), 597–603.
21. McCurry, S.M., Logsdon, R.G., Teri, L., Gibbons, L.E., Kukull, W.A., Bowen, J.D., et al. Characteristics of sleep disturbance in community-dwelling Alzheimer's disease patients. J Geriatr Psychiatry Neurol 12:2 (1999), 53–59.
22. Prinz, P.N., Vitiello, M.V., Raskind, M.A., Thorpy, M.J., Geriatrics: sleep disorders and aging. N Engl J Med 323:8 (1990), 520–526.
23. Moe, K.E., Vitiello, M.V., Larsen, L.H., Prinz, P.N., Symposium: cognitive processes and sleep disturbances: sleep/wake patterns in Alzheimer's disease: relationships with cognition and function. J Sleep Res 4:1 (1995), 15–20.
24. Pollak, C.P., Perlick, D., Sleep problems and institutionalization of the elderly. J Geriatr Psychiatry Neurol 4:4 (1991), 204–210.
25. Harper, D.G., Stopa, E.G., Kuo-Leblanc, V., McKee, A.C., Asayama, K., Volicer, L., et al. Dorsomedial SCN neuronal subpopulations subserve different functions in human dementia. Brain J Neurol 131:Pt. 6 (2008), 1609–1617.
26. Skene, D.J., Swaab, D.F., Melatonin rhythmicity: effect of age and Alzheimer's disease. Exp Gerontol 38:1–2 (2003), 199–206.
27. Stopa, E.G., Volicer, L., Kuo-Leblanc, V., Harper, D., Lathi, D., Tate, B., et al. Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. J Neuropathol Exp Neurol 58:1 (1999), 29–39.
28. Swaab, D.F., Fliers, E., Partiman, T.S., The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res 342:1 (1985), 37–44.
29. Tranah, G.J., Blackwell, T., Stone, K.L., Ancoli-Israel, S., Paudel, M.L., Ensrud, K.E., et al. Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann Neurol 70:5 (2011), 722–732.
30. Ukai, H., Ueda, H.R., Systems biology of mammalian circadian clocks. Annu Rev Physiol 72 (2010), 579–603.
31. Aguilar-Roblero, R., Drucker-Colin, R., Moore, R.Y., Behavioral and morphological studies of fetal neural transplants into SCN-lesioned rats. Chronobiol Int 9:4 (1992), 278–296.
32. DeCoursey, P.J., Buggy, J., Circadian rhythmicity after neural transplant to hamster third ventricle: specificity of suprachiasmatic nuclei. Brain Res 500:1–2 (1989), 263–275.
33. Lehman, M.N., Silver, R., Gladstone, W.R., Kahn, R.M., Gibson, M., Bittman, E.L., Circadian rhythmicity restored by neural transplant. Immunocytochemical characterization of the graft and its integration with the host brain. J Neurosci Offic J Soc Neurosci 7:6 (1987), 1626–1638.
34. Ralph, M.R., Foster, R.G., Davis, F.C., Menaker, M., Transplanted suprachiasmatic nucleus determines circadian period. Science (New York, NY) 247:4945 (1990), 975–978.
35. Abrahamson, E.E., Moore, R.Y., Suprachiasmatic nucleus in the mouse: retinal innervation, intrinsic organization and efferent projections. Brain Res 916:1–2 (2001), 172–191.
36. Groblewski, T.A., Nunez, A.A., Gold, R.M., Circadian rhythms in vasopressin deficient rats. Brain Res Bull 6:2 (1981), 125–130.
37. Stoinev, A.G., Ikonomov, O., Effects of continuous infusion of vasopressin on circadian rhythms of food and water intake, urine output and electrolyte excretion in Brattleboro rats. Biulleten' eksperimental'noi biologii i meditsiny 109:2 (1990), 109–111.
38. Brown, M.H., Nunez, A.A., Vasopressin-deficient rats show a reduced amplitude of the circadian sleep rhythm. Physiol Behav 46:4 (1989), 759–762.
39. Aton, S.J., Colwell, C.S., Harmar, A.J., Waschek, J., Herzog, E.D., Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons. Nat Neurosci 8:4 (2005), 476–483.
40. Coogan, A.N., Rawlings, N., Luckman, S.M., Piggins, H.D., Effects of neurotensin on discharge rates of rat suprachiasmatic nucleus neurons in vitro. Neuroscience 103:3 (2001), 663–672.
41. Meyer-Spasche, A., Reed, H.E., Piggins, H.D., Neurotensin phase-shifts the firing rate rhythm of neurons in the rat suprachiasmatic nuclei in vitro. Eur J Neurosci 16:2 (2002), 339–344.
42. Alexander, M.J., Leeman, S.E., Widespread expression in adult rat forebrain of mRNA encoding high-affinity neurotensin receptor. J Comp Neurol 402:4 (1998), 475–500.
43. Boudin, H., Pelaprat, D., Rostene, W., Beaudet, A., Cellular distribution of neurotensin receptors in rat brain: immunohistochemical study using an antipeptide antibody against the cloned high affinity receptor. J Comp Neurol 373:1 (1996), 76–89.
44. Francois-Bellan, A.M., Bosler, O., Tonon, M.C., Wei, L.T., Beaudet, A., Association of neurotensin receptors with VIP-containing neurons and serotonin-containing axons in the suprachiasmatic nucleus of the rat. Synapse (New York, NY) 10:4 (1992), 282–290.
45. Hendrickson, A.E., Wagoner, N., Cowan, W.M., An autoradiographic and electron microscopic study of retino-hypothalamic connections. Z Zellforsch Mikrosk Anat (Vienna, Austria: 1948) 135:1 (1972), 1–26.
46. Moore, R.Y., Lenn, N.J., A retinohypothalamic projection in the rat. J Comp Neurol 146:1 (1972), 1–14.
47. Mistlberger, R.E., Skene, D.J., Nonphotic entrainment in humans?. J Biol Rhythms 20:4 (2005), 339–352.
48. Sack, R.L., Lewy, A.J., Blood, M.L., Keith, L.D., Nakagawa, H., Circadian rhythm abnormalities in totally blind people: incidence and clinical significance. J Clin Endocrinol Metabol 75:1 (1992), 127–134.
49. Gekakis, N., Staknis, D., Nguyen, H.B., Davis, F.C., Wilsbacher, L.D., King, D.P., et al. Role of the CLOCK protein in the mammalian circadian mechanism. Science (New York, NY) 280:5369 (1998), 1564–1569.
50. Akashi, M., Tsuchiya, Y., Yoshino, T., Nishida, E., Control of intracellular dynamics of mammalian period proteins by casein kinase I epsilon (CKIepsilon) and CKIdelta in cultured cells. Mol Cell Biol 22:6 (2002), 1693–1703.
51. Langmesser, S., Tallone, T., Bordon, A., Rusconi, S., Albrecht, U., Interaction of circadian clock proteins PER2 and CRY with BMAL1 and CLOCK. BMC Mol Biol 9:1 (2008), 1–16.
52. Fu, L., Lee, C.C., The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 3:5 (2003), 350–361.
53. Guillaumond, F., Dardente, H., Giguere, V., Cermakian, N., Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J Biol Rhythms 20:5 (2005), 391–403.
54. Kwon, I., Lee, J., Chang, S.H., Jung, N.C., Lee, B.J., Son, G.H., et al. BMAL1 shuttling controls transactivation and degradation of the CLOCK/BMAL1 heterodimer. Mol Cell Biol 26:19 (2006), 7318–7330.
55. Gerstner, J.R., Yin, J.C., Circadian rhythms and memory formation. Nat Rev Neurosci 11:8 (2010), 577–588.
56. Hasegawa, K., Saigusa, T., Tamai, Y., Caenorhabditis elegans opens up new insights into circadian clock mechanisms. Chronobiol Int 22:1 (2005), 1–19.
57. Laposky, A., Easton, A., Dugovic, C., Walisser, J., Bradfield, C., Turek, F., Deletion of the mammalian circadian clock gene BMAL1/Mop3 alters baseline sleep architecture and the response to sleep deprivation. Sleep 28:4 (2005), 395–409.
58. Shiromani, P.J., Xu, M., Winston, E.M., Shiromani, S.N., Gerashchenko, D., Weaver, D.R., Sleep rhythmicity and homeostasis in mice with targeted disruption of mPeriod genes. Am J Physiol Regul Integr Comp Physiol 287:1 (2004), R47–R57.
59. Wisor, J.P., O'Hara, B.F., Terao, A., Selby, C.P., Kilduff, T.S., Sancar, A., et al. A role for cryptochromesin sleep regulation. BMC Neurosci 3:1 (2002), 1–14.
60. Welsh, D.K., Takahashi, J.S., Kay, S.A., Suprachiasmatic nucleus: cell autonomy and network properties. Annu Rev Physiol 72 (2010), 551–577.
61. Abrahamson, E.E., Leak, R.K., Moore, R.Y., The suprachiasmatic nucleus projects to posterior hypothalamic arousal systems. NeuroReport, 12(2), 2001.
62. Buijs, R.M., van Eden, C.G., Goncharuk, V.D., Kalsbeek, A., The biological clock tunes the organs of the body: timing by hormones and the autonomic nervous system. J Endocrinol 177:1 (2003), 17–26.
63. Dai, J., Swaab, D.F., Buijs, R.M., Distribution of vasopressin and vasoactive intestinal polypeptide (VIP) fibers in the human hypothalamus with special emphasis on suprachiasmatic nucleus efferent projections. J Comp Neurol 383:4 (1997), 397–414.
64. Deurveilher, S., Semba, K., Indirect projections from the suprachiasmatic nucleus to major arousal-promoting cell groups in rat: implications for the circadian control of behavioural state. Neuroscience 130:1 (2005), 165–183.
65. Kriegsfeld, L.J., Leak, R.K., Yackulic, C.B., LeSauter, J., Silver, R.A.E., Organization of suprachiasmatic nucleus projections in Syrian hamsters (Mesocricetus auratus): an anterograde and retrograde analysis. J Comp Neurol 468:3 (2004), 361–379.
66. Saper, C.B., Lu, J., Chou, T.C., Gooley, J., The hypothalamic integrator for circadian rhythms. Trends Neurosci 28:3 (2005), 152–157.
67. Watts, A.G., Swanson, L.W., Efferent projections of the suprachiasmatic nucleus: II. Studies using retrograde transport of fluorescent dyes and simultaneous peptide immunohistochemistry in the rat. J Comp Neurol 258:2 (1987), 230–252.
68. Watts, A.G., Swanson, L.W., Sanchez-Watts, G., Efferent projections of the suprachiasmatic nucleus: I. Studies using anterograde transport of Phaseolus vulgaris leucoagglutinin in the rat. J Comp Neurol 258:2 (1987), 204–229.
69. Franklin, K.B.J., Paxinos, G., The mouse brain in stereotactic coordinates. 2008.
70. Lu, J., Zhang, Y.H., Chou, T.C., Gaus, S.E., Elmquist, J.K., Shiromani, P., et al. Contrasting effects of Ibotenate lesions of the paraventricular nucleus and subparaventricular zone on sleep–wake cycle and temperature regulation. J Neurosci Offic J Soc Neurosci 21:13 (2001), 4864–4874.
71. Chou, T.C., Bjorkum, A.A., Gaus, S.E., Lu, J., Scammell, T.E., Saper, C.B., Afferents to the ventrolateral preoptic nucleus. J Neurosci, 22(3), 2002, 977.
72. Chou, T.C., Scammell, T.E., Gooley, J.J., Gaus, S.E., Saper, C.B., Lu, J., Critical role of dorsomedial hypothalamic nucleus in a wide range of behavioral circadian rhythms. J Neurosci 23:33 (2003), 10691–10702.
73. Thompson, R.H., Canteras, N.S., Swanson, L.W., Organization of projections from the dorsomedial nucleus of the hypothalamus: a PHA-L study in the rat. J Comp Neurol 376:1 (1996), 143–173.
74. Moore, R.Y., Neural control of the pineal gland. Behav Brain Res 73:1–2 (1996), 125–130.
75. Castel, M., Morris, J.F., Morphological heterogeneity of the GABAergic network in the suprachiasmatic nucleus, the brain's circadian pacemaker. J Anat 196:Pt. 1 (2000), 1–13.
76. Csáki, A., Kocsis, K., Halász, B., Kiss, J., Localization of glutamatergic/aspartatergic neurons projecting to the hypothalamic paraventricular nucleus studied by retrograde transport of [3H]D-aspartate autoradiography. Neuroscience 101:3 (2000), 637–655.
77. Cui, L.-N., Coderre, E., Renaud, L.P., Glutamate and GABA mediate suprachiasmatic nucleus inputs to spinal-projecting paraventricular neurons. Am J Physiol Regul Integr Comp Physiol, 281(4), 2001, R1283.
78. Kalsbeek, A., Garidou, M.-L., Palm, I.F., Van Der Vliet, J., Simonneaux, V., Pévet, P., et al. Melatonin sees the light: blocking GABA-ergic transmission in the paraventricular nucleus induces daytime secretion of melatonin. Eur J Neurosci 12:9 (2000), 3146–3154.
79. Perreau-Lenz, S., Kalsbeek, A., Pévet, P., Buijs, R.M., Glutamatergic clock output stimulates melatonin synthesis at night. Eur J Neurosci 19:2 (2004), 318–324.
80. Kalsbeek, A., La Fleur, S., Van Heijningen, C., Buijs, R.M., Suprachiasmatic GABAergic inputs to the paraventricular nucleus control plasma glucose concentrations in the rat via sympathetic innervation of the liver. J Neurosci, 24(35), 2004, 7604.
81. Liu, C., Weaver, D.R., Jin, X., Shearman, L.P., Pieschl, R.L., Gribkoff, V.K., et al. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 19:1 (1997), 91–102.
82. Silver, R., LeSauter, J., Tresco, P.A., Lehman, M.N., A diffusible coupling signal from the transplanted suprachiasmatic nucleus controlling circadian locomotor rhythms. Nature 382:6594 (1996), 810–813.
83. Kramer, A., Yang, F.-C., Snodgrass, P., Li, X., Scammell, T.E., Davis, F.C., et al. Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signaling. Science (New York, NY), 294(5551), 2001, 2511.
84. Cheng, M.Y., Bullock, C.M., Li, C., Lee, A.G., Bermak, J.C., Belluzzi, J., et al. Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature 417:6887 (2002), 405–410.
85. Inouye, S.T., Kawamura, H., Characteristics of a circadian pacemaker in the suprachiasmatic nucleus. J Comp Physiol 146:2 (1982), 153–160.
86. Inouye, S.T., Kawamura, H., Persistence of circadian rhythmicity in a mammalian hypothalamic “island” containing the suprachiasmatic nucleus. Proc Natl Acad Sci U S A 76:11 (1979), 5962–5966.
87. Sato, T., Kawamura, H., Circadian rhythms in multiple unit activity inside and outside the suprachiasmatic nucleus in the diurnal chipmunk (Eutamias sibiricus). Neurosci Res 1:1 (1984), 45–52.
88. Yamazaki, S., Kerbeshian, M.C., Hocker, C.G., Block, G.D., Menaker, M., Rhythmic properties of the hamster suprachiasmatic nucleus in vivo. J Neurosci Offic J Soc Neurosci 18:24 (1998), 10709–10723.
89. Novak, C.M., Ehlen, J.C., Paul, K.N., Fukuhara, C., Albers, H.E., Light and GABAA receptor activation alter period mRNA levels in the SCN of diurnal Nile grass rats. Eur J Neurosci 24:10 (2006), 2843–2852.
90. Nygard, M., Hill, R.H., Wikstrom, M.A., Kristensson, K., Age-related changes in electrophysiological properties of the mouse suprachiasmatic nucleus in vitro. Brain Res Bull 65:2 (2005), 149–154.
91. Bentivoglio, M., Deng, X.H., Nygård, M., Sadki, A., Kristensson, K., The aging suprachiasmatic nucleus and cytokines: functional, molecular, and cellular changes in rodents. Chronobiol Int 23:1–2 (2006), 437–449.
92. Hurd, M.W., Ralph, M.R., The significance of circadian organization for longevity in the golden hamster. J Biol Rhythms 13:5 (1998), 430–436.
93. Li, H., Satinoff, E., Fetal tissue containing the suprachiasmatic nucleus restores multiple circadian rhythms in old rats. Am J Physiol 275:6 Pt. 2 (1998), R1735–R1744.
94. Madeira, M.D., Sousa, N., Santer, R.M., Paula-Barbosa, M.M., Gundersen, H.J., Age and sex do not affect the volume, cell numbers, or cell size of the suprachiasmatic nucleus of the rat: an unbiased stereological study. J Comp Neurol 361:4 (1995), 585–601.
95. Tsukahara, S., Tanaka, S., Ishida, K., Hoshi, N., Kitagawa, H., Age-related change and its sex differences in histoarchitecture of the hypothalamic suprachiasmatic nucleus of F344/N rats. Exp Gerontol 40:3 (2005), 147–155.
96. Roberts, D.E., Killiany, R.J., Rosene, D.L., Neuron numbers in the hypothalamus of the normal aging rhesus monkey: stability across the adult lifespan and between the sexes. J Comp Neurol 520:6 (2012), 1181–1197.
97. Angelie, E., Bonmartin, A., Boudraa, A., Gonnaud, P.M., Mallet, J.J., Sappey-Marinier, D., Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study. AJNR Am J Neuroradiol 22:1 (2001), 119–127.
98. Lu, T., Pan, Y., Kao, S.-Y., Li, C., Kohane, I., Chan, J., et al. Gene regulation and DNA damage in the ageing human brain. Nature 429:6994 (2004), 883–891.
99. Ohyama, H., Hiramatsu, M., Ogawa, N., Mori, A., Age-related differences in synaptosomal membrane fluidity. Biochem Mol Biol Int 37:1 (1995), 133–140.
100. Eckert, G.P., Cairns, N.J., Maras, A., Gattaz, W.F., Muller, W.E., Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease. Dementia Geriatr Cognitive Disord 11:4 (2000), 181–186.
101. Nagy, K., Nagy, V., Bertoni-Freddari, C., Nagy, I., Alterations of the synaptosomal membrane ‘microviscosity’ in the brain cortex of rats during aging and centrophenoxine treatment. Archives Gerontol Geriatr 2:1–2 (1983), 23–39.
102. Carmena, M.J., Hueso, C., Guijarro, L.G., Prieto, J.C., Cholesterol modulation of membrane fluidity and VIP receptor/effector system in rat prostatic epithelial cells. Regul Pept 33:3 (1991), 287–297.
103. Scheuer, K., Stoll, S., Paschke, U., Weigel, R., Muller, W.E., N-methyl-D-aspartate receptor density and membrane fluidity as possible determinants of the decline of passive avoidance performance in aging. Pharmacol Biochem Behav 50:1 (1995), 65–70.
104. Zhou, J.-N., Swaab, D.F., Activation and degeneration during aging: a morphometric study of the human hypothalamus. Microsc Res Tech 44:1 (1999), 36–48.
105. Hofman, M.A., Swaab, D.F., Alterations in circadian rhythmicity of the vasopressin-producing neurons of the human suprachiasmatic nucleus (SCN) with aging. Brain Res 651:1–2 (1994), 134–142.
106. Farajnia, S., Michel, S., Deboer, T., vanderLeest, H.T., Houben, T., Rohling, J.H., et al. Evidence for neuronal desynchrony in the aged suprachiasmatic nucleus clock. J Neurosci Offic J Soc Neurosci 32:17 (2012), 5891–5899.
107. Liu, R.Y., Zhou, J.N., Hoogendijk, W.J., van Heerikhuize, J., Kamphorst, W., Unmehopa, U.A., et al. Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression. J Neuropathol Exp Neurol 59:4 (2000), 314–322.
108. Zhou, J.N., Hofman, M.A., Swaab, D.F., VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease. Neurobiol Aging 16:4 (1995), 571–576.
109. Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G.M., et al. Inflammation and Alzheimer's disease. Neurobiol Aging 21:3 (2000), 383–421.
110. Yin, Z., Raj, D., Saiepour, N., Van Dam, D., Brouwer, N., Holtman, I.R., et al. Immune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease. Neurobiol Aging 55 (2017), 115–122.
111. Rogers, J., Kirby, L.C., Hempelman, S.R., Berry, D.L., McGeer, P.L., Kaszniak, A.W., et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology 43:8 (1993), 1609–1611.
112. Quinn, J., Montine, T., Morrow, J., Woodward, W.R., Kulhanek, D., Eckenstein, F., Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease. J Neuroimmunol 137:1 (2003), 32–41.
113. Weggen, S., Eriksen, J.L., Das, P., Sagi, S.A., Wang, R., Pietrzik, C.U., et al. A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity. Nature 414:6860 (2001), 212–216.
114. Ogomori, K., Kitamoto, T., Tateishi, J., Sato, Y., Suetsugu, M., Abe, M., Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease. Am J Pathol 134:2 (1989), 243–251.
115. Standaert, D.G., Lee, V.M., Greenberg, B.D., Lowery, D.E., Trojanowski, J.Q., Molecular features of hypothalamic plaques in Alzheimer's disease. Am J Pathol 139:3 (1991), 681–691.
116. Purkayastha, S., Cai, D., Disruption of neurogenesis by hypothalamic inflammation in obesity or aging. Rev Endocr Metabol Disord, 14(4), 2013, 10.1007/s11154-013-9279-z.
117. Zhang, G., Li, J., Purkayastha, S., Tang, Y., Zhang, H., Yin, Y., et al. Hypothalamic programming of systemic aging involving IKKβ/NF-κB and GnRH. Nature 497:7448 (2013), 211–216.
118. Cohen, R.A., Albers, E.H., Disruption of human circadian and cognitive regulation following a discrete hypothalamic lesion: a case study. Neurology 41:5 (1991), 726–729.
119. Schwartz, W., Busis, N., Tessa Hedley-Whyte, E., A discrete lesion of ventral hypothalamus and optic chiasm that disturbed the daily temperature rhythm. J Neurol 233:1 (1986), 1–4.
120. Liu, X.-G., Zhang, B.-J., Xu, X.-H., Huang, Z.-L., Qu, W.-M., Lesions of suprachiasmatic nucleus modify sleep structure but do not alter the total amount of daily sleep in rats. Sleep Biol Rhythms 10:4 (2012), 293–301.
121. Sterniczuk, R., Dyck, R.H., Laferla, F.M., Antle, M.C., Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes Brain Res 1348 (2010), 139–148.
122. Xie, L., Kang, H., Xu, Q., Chen, M.J., Liao, Y., Thiyagarajan, M., et al. Sleep drives metabolite clearance from the adult brain. Science (New York, NY) 342:6156 (2013), 373–377.
123. Kang, J.E., Lim, M.M., Bateman, R.J., Lee, J.J., Smyth, L.P., Cirrito, J.R., et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science (New York, NY) 326:5955 (2009), 1005–1007.
124. Roh, J.H., Huang, Y., Bero, A.W., Kasten, T., Stewart, F.R., Bateman, R.J., et al. Disruption of the sleep-wake cycle and diurnal fluctuation of beta-amyloid in mice with Alzheimer's disease pathology. Sci Transl Med, 4(150), 2012 150ra22.
125. Tate, B., Aboody-Guterman, K.S., Morris, A.M., Walcott, E.C., Majocha, R.E., Marotta, C.A., Disruption of circadian regulation by brain grafts that overexpress Alzheimer beta/A4 amyloid. Proc Natl Acad Sci U S A 89:15 (1992), 7090–7094.
126. Furio, A.M., Cutrera, R.A., Thea, V.C., Lloret, S.P., Riccio, P., Caccuri, R.L., et al. Effect of melatonin on changes in locomotor activity rhythm of Syrian hamsters injected with beta amyloid peptide 25–35 in the suprachiasmatic nuclei. Cell Mol Neurobiol 22:5 (2002), 699–709.
127. Chen, K.F., Possidente, B., Lomas, D.A., Crowther, D.C., The central molecular clock is robust in the face of behavioural arrhythmia in a Drosophila model of Alzheimer's disease. Dis Models Mech 7:4 (2014), 445–458.
128. Ng, F.S., Tangredi, M.M., Jackson, F.R., Glial cells physiologically modulate clock neurons and circadian behavior in a calcium-dependent manner. Curr Biol 21:8 (2011), 625–634.
129. Karatsoreos, I.N., Bhagat, S., Bloss, E.B., Morrison, J.H., McEwen, B.S., Disruption of circadian clocks has ramifications for metabolism, brain, and behavior. Proc Natl Acad Sci 108:4 (2011), 1657–1662.
130. Musiek, E.S., Lim, M.M., Yang, G., Bauer, A.Q., Qi, L., Lee, Y., et al. Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration. J Clin Investig 123:12 (2013), 5389–5400.
131. Katz, B., Rimmer, S., Iragui, V., Katzman, R., Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration?. Ann Neurol 26:2 (1989), 221–225.
132. Hinton, D.R., Sadun, A.A., Blanks, J.C., Miller, C.A., Optic-nerve degeneration in Alzheimer's disease. N Engl J Med 315:8 (1986), 485–487.
133. Klaver, C.C., Ott, A., Hofman, A., Assink, J.J., Breteler, M.M., de Jong, P.T., Is age-related maculopathy associated with Alzheimer's disease? The Rotterdam study. Am J Epidemiol 150:9 (1999), 963–968.
134. Bayer, A.U., Ferrari, F., Erb, C., High occurrence rate of glaucoma among patients with Alzheimer's disease. Eur Neurol 47:3 (2002), 165–168.
135. Tamura, H., Kawakami, H., Kanamoto, T., Kato, T., Yokoyama, T., Sasaki, K., et al. High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease. J Neurolog Sci 246:1–2 (2006), 79–83.
136. Wostyn, P., Audenaert, K., De Deyn, P.P., Alzheimer's disease and glaucoma: is there a causal relationship?. Br J Ophthalmol, 93(12), 2009, 1557.
137. Wostyn, P., De Groot, V., Van Dam, D., Audenaert, K., Killer, H.E., De Deyn, P.P., Alzheimer's disease and glaucoma: can glymphatic system dysfunction underlie their comorbidity?. Acta Ophthalmol 95:3 (2017), e244–e245.
138. Mott, R.T., Hulette, C.M., Neuropathology of Alzheimer's disease. Neuroimaging Clin N Am 15:4 (2005), 755–765 ix.
139. Madeira, M.D., Pereira, P.A., Silva, S.M., Cadete-Leite, A., Paula-Barbosa, M.M., Basal forebrain neurons modulate the synthesis and expression of neuropeptides in the rat suprachiasmatic nucleus. Neuroscience 125:4 (2004), 889–901.
140. Erhardt, C., Galani, R., Jeltsch, H., Cassel, J.C., Klosen, P., Menet, J.S., et al. Modulation of photic resetting in rats by lesions of projections to the suprachiasmatic nuclei expressing p75 neurotrophin receptor. Eur J Neurosci 19:7 (2004), 1773–1788.
141. Craig, L.A., Hong, N.S., Kopp, J., McDonald, R.J., Cholinergic depletion of the medial septum followed by phase shifting does not impair memory or rest-activity rhythms measured under standard light/dark conditions in rats. Brain Res Bull 79:1 (2009), 53–62.
142. Gais, S., Born, J., Low acetylcholine during slow-wave sleep is critical for declarative memory consolidation. Proc Natl Acad Sci U S A 101:7 (2004), 2140–2144.
143. Burns, A., Rossor, M., Hecker, J., Gauthier, S., Petit, H., Möller, H.J., et al. The effects of donepezil in Alzheimer's disease – results from a multinational trial. Dementia Geriatr Cognit Disord 10:3 (1999), 237–244.
144. Zhou, J.-N., Liu, R.-Y., van Heerikhuize, J., Hofman, M.A., Swaab, D.F., Alterations in the circadian rhythm of salivary melatonin begin during middle-age. J Pineal Res 34:1 (2003), 11–16.
145. Liu, R.Y., Zhou, J.N., van Heerikhuize, J., Hofman, M.A., Swaab, D.F., Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype. J Clin Endocrinol Metabol 84:1 (1999), 323–327.
146. Wu, Y.H., Zhou, J.N., Van Heerikhuize, J., Jockers, R., Swaab, D.F., Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer's disease. Neurobiol Aging 28:8 (2007), 1239–1247.
147. Baskett, J.J., Broad, J.B., Wood, P.C., Duncan, J.R., Pledger, M.J., English, J., et al. Does melatonin improve sleep in older people? A randomised crossover trial. Age Ageing 32:2 (2003), 164–170.
148. Hughes, R.J., Sack, R.L., Lewy, A.J., The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement. Sleep 21:1 (1998), 52–68.
149. Jean-Louis, G., von Gizycki, H., Zizi, F., Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment. J Pineal Res 25:3 (1998), 177–183.
150. Zhdanova, I.V., Wurtman, R.J., Regan, M.M., Taylor, J.A., Shi, J.P., Leclair, O.U., Melatonin treatment for age-related insomnia. J Clin Endocrinol Metabol 86:10 (2001), 4727–4730.
151. Yesavage, J.A., Friedman, L., Ancoli-Israel, S., Bliwise, D., Singer, C., Vitiello, M.V., et al. Development of diagnostic criteria for defining sleep disturbance in Alzheimer's disease. J Geriatr Psychiatry Neurol 16:3 (2003), 131–139.
152. Maywood, E.S., Mrosovsky, N., Field, M.D., Hastings, M.H., Rapid down-regulation of mammalian Period genes during behavioral resetting of the circadian clock. Proc Natl Acad Sci U S A 96:26 (1999), 15211–15216.
153. Shochat, T., Martin, J., Marler, M., Ancoli-Israel, S., Illumination levels in nursing home patients: effects on sleep and activity rhythms. J Sleep Res 9:4 (2000), 373–379.
154. Ancoli-Israel, S., Gehrman, P., Martin, J.L., Shochat, T., Marler, M., Corey-Bloom, J., et al. Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer's disease patients. Behav Sleep Med 1:1 (2003), 22–36.
155. Yamadera, H., Ito, T., Suzuki, H., Asayama, K., Ito, R., Endo, S., Effects of bright light on cognitive and sleep-wake (circadian) rhythm disturbances in Alzheimer-type dementia. Psychiatry Clin Neurosci 54:3 (2000), 352–353.
156. Najjar, R.P., Zeitzer, J.M., Temporal integration of light flashes by the human circadian system. J Clin Investig 126:3 (2016), 938–947.
157. Riemersma-van der Lek, R.F., Swaab, D.F., Twisk, J., Hol, E.M., Hoogendijk, W.J., Van Someren, E.J., Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. Jama 299:22 (2008), 2642–2655.
158. Vieira, E., Burris, T.P., Quesada, I., Clock genes, pancreatic function, and diabetes. Trends Mol Med 20:12 (2014), 685–693.
159. Fuller, P.M., Gooley, J.J., Saper, C.B., Neurobiology of the sleep-wake cycle: sleep architecture, circadian regulation, and regulatory feedback. J Biol Rhythms 21:6 (2006), 482–493.